HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.

AbstractPURPOSE:
The present study was conducted to evaluate the diagnostic and prognostic values of serum autoantibody against matrix metalloproteinase-7 (MMP-7) in patients with oral squamous cell carcinoma (OSCC).
MATERIALS AND METHODS:
Anti-MMP-7 antibodies were measured in sera from 204 patients with OSCC and 212 normal controls using enzyme-linked immunosorbent assay, and clinicopathologic characteristics were correlated. Prognostic consequence was assessed with Kaplan-Meier curve and log-rank tests using Cox proportional hazard models. To check whether anti-MMP-7 antibody was related to tumor associated antigen, real-time polymerase chain reaction and western blot were used to measure MMP-7 mRNA and protein expression in tumor tissues from all 204 patients with OSCC.
RESULTS:
Serum anti-MMP-7 antibody was higher in patients with OSCC (P < .05), and those with poorly differentiated tumors had more anti-MMP-7 antibody than those with well to moderate tumor differentiation (P < .01, P < .01, respectively). Patients with OSCC at late TNM stages (III, IV) and lymph node metastases had relatively higher serum anti-MMP-7 antibody levels than those with earlier stages (I, II) and those who lacked lymph node metastases (P < .05 for the 2 comparisons). OSCC prediction sensitivity as measured by receiver operating characteristics analysis was 0.485 and specificity was 0.896 (area under the curve, 0.761; 95% confidence interval, 0.716 to 0.806). Cox analysis showed that serum anti-MMP-7 antibody positivity independently predicted poor overall survival in patients with OSCC (hazard ratio, 1.82; 95% confidence interval, 1.07 to 4.61). MMP-7 mRNA and protein expression was increased in tumor tissues from patients with OSCC and high serum anti-MMP-7 antibody.
CONCLUSION:
Serum anti-MMP-7 antibody might be a novel diagnostic and prognostic biomarker for OSCC.
AuthorsTao Jiang, Pengfeng Xie, Hongchen Liu
JournalJournal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons (J Oral Maxillofac Surg) Vol. 74 Issue 3 Pg. 650-7 (Mar 2016) ISSN: 1531-5053 [Electronic] United States
PMID26454036 (Publication Type: Comparative Study, Journal Article)
CopyrightCopyright © 2016 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Autoantibodies
  • Biomarkers, Tumor
  • MMP7 protein, human
  • Matrix Metalloproteinase 7
Topics
  • Aged
  • Area Under Curve
  • Autoantibodies (blood)
  • Biomarkers, Tumor (blood)
  • Carcinoma, Squamous Cell (blood, diagnosis, pathology)
  • Case-Control Studies
  • Electrophoresis, Polyacrylamide Gel (methods)
  • Female
  • Follow-Up Studies
  • Humans
  • Lymphatic Metastasis (pathology)
  • Male
  • Matrix Metalloproteinase 7 (analysis, immunology)
  • Middle Aged
  • Mouth Neoplasms (blood, diagnosis, pathology)
  • Neoplasm Grading
  • Neoplasm Staging
  • Prognosis
  • Proportional Hazards Models
  • ROC Curve
  • Retrospective Studies
  • Sensitivity and Specificity
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: